NeuBase Therapeutics, Inc. announced a private placement of 1,366,829 common shares at an issue price of $2.57 per share for gross proceeds of $3,512,750.53 on June 28, 2023. The company also issued unregistered Series A warrants to purchase up to an aggregate of 1,945,526 shares of common stock and unregistered short-term Series B warrants to purchase up to an aggregate of 1,945,526 shares of common stock.